Skip to main content
Clinical Trials/NCT02971163
NCT02971163
Completed
Not Applicable

SynDA: Syncope Decision Aid for Emergency Care

Icahn School of Medicine at Mount Sinai1 site in 1 country50 target enrollmentJanuary 2017
ConditionsSyncope

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Syncope
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment
50
Locations
1
Primary Endpoint
Number of Participants at End of Study
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Syncope, or transient loss of consciousness/fainting, is a common emergency department (ED) complaint responsible for over 1 million ED visits yearly. Potential causes include benign conditions such as dehydration or vaso-vagal syncope. Rarely, syncope is the result of serious cardiac conditions. In older patients without a clear cause of syncope hospital admission is frequently initiated at very low risk thresholds, though there is little evidence that these admissions improve patient outcomes. These decisions are often made without significant patient input or discussion of reasonable alternatives. In this situation, a patient's values, preferences, and particular circumstances should be taken into account. This mutualistic approach to clinical management is referred to as Shared Decision-Making. Shared Decision-Making (SDM) is a joint process of choice selection between providers and patients in clinical scenarios where multiple reasonable management options exist. To improve syncope emergency care, the researchers can leverage recent advances in risk stratification to engage patients in SDM and deliver superior, patient-centered care.

This study will provide the groundwork for a larger, randomized controlled trial evaluating the effects of the decision aid for management of low-risk syncope.

Detailed Description

Setting: Mount Sinai Hospital (MSH) has a 61-bed adult Emergency Department with a volume of over 100,000 patient visits/year or approximately 300 visits/day. MSH is a large academic tertiary care medical center located in East Harlem and serves a large black and Hispanic community. Projected Recruitment: There are approximately 60 MSH ED visits for syncope per month of which 35 per month are by patients above age 30. Roughly half of these do not have a clear etiology of their syncope discovered in the ED. The researchers project that of the 17 potentially eligible patients per month, three will be successfully enrolled for a projected 72 patient enrollees at the completion of the 24-month recruitment period. The PI, clinical research coordinators, and SRAs will monitor the real-time electronic tracking system for all ED patients and will identify any patient over age 30 with a chief complaint of syncope or loss of consciousness.

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
January 9, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Emergency Department patient
  • Age 30 years or above
  • Chief complaint of syncope
  • Capacity to make medical decisions
  • Speak and read English
  • Working phone number and fixed address

Exclusion Criteria

  • Altered Mental Status
  • Cognitive Impairment
  • Serious acute diagnosis:
  • (e.g. clinically significant cardiac dysrhythmia, structural heart disease, gastrointestinal hemorrhage, myocardial infarction, pulmonary embolism, pneumonia, arterial dissection, serious infection, ectopic pregnancy, subarachnoid hemorrhage, or stroke.)
  • Hemodynamic instability
  • Inability to read or speak English
  • Major communication barrier
  • Lack of phone number or fixed address
  • Too high risk as per physician judgment

Outcomes

Primary Outcomes

Number of Participants at End of Study

Time Frame: Two years

Feasibility of the study will be measured by the number of participants successfully enrolled at the end of the study period.

Secondary Outcomes

  • Participants With New Significant Clinical Diagnosis(at 30 days)
  • Patient Knowledge(Within 2 hours post ED disposition on Day 1)
  • Utilization Outcomes(Day 1 and 30 day follow up period)
  • Number of Diagnostic Testing(Day 1)
  • Decisional Conflict Scale(Within 2 hours post ED disposition on Day 1)
  • Number of Participants With Repeat Visits to the ED(30-day follow-up period)
  • OPTION-5 Scale(up to 2 years)

Study Sites (1)

Loading locations...

Similar Trials